Leonard Zehr, Author at BioTuesdays

Developments

MIT-led research team unveil oral insulin capsule for Type 2 diabetes

Researchers from the Massachusetts Institute of Technology, Brigham and Women’s Hospital and Novo Nordisk have come up with an oral insulin pill that could replace injections for patients with Type 2 diabetes, according...

February 11, 2019

Feature

Interface Biologics to focus future growth in biotech with local drug delivery platform

Closely-held Interface Biologics, best known for improving the safety and efficacy of medical devices through its Endexo surface modification technology, is pegging its future growth on biotech, with an initial focus on...

February 5, 2019

Feature

Karius diagnostic test enabling precision medicine for infectious diseases

Closely-held Karius has developed and commercialized a next-generation sequencing test that can identify and quantify microbial cell-free DNA from more than 1,300 bacteria, viruses, fungi and parasites using a non...

January 29, 2019

Feature

Novavax to report key vaccine data in first quarter

Novavax (NASDAQ:NVAX) is scheduled to report pivotal data in the current quarter for ResVax, its RSV (respiratory syncytial virus) F vaccine, using aluminum phosphate as an adjuvant, in infants via maternal immunization.

January 22, 2019

Feature

Titan Pharma relaunch of Probuphine paying early dividends

Titan Pharmaceuticals’ (NASDAQ:TTNP) relaunch of its Probuphine implant for the long-term maintenance treatment of opioid use disorder (OUD) demonstrated promising results with a meaningful increase in product shipments...

January 15, 2019

Feature

BeyondSpring readies NDA filings for Plinabulin in U.S. and China

BeyondSpring (NASDAQ:BYSI) is preparing to file NDAs with the China FDA during the next six months for its lead asset, first-in-class agent Plinabulin, for the treatment of non-small cell lung cancer (NSCLC) and...

January 8, 2019

Feature

iBio spearheading plant-based biopharmaceuticals at CDMO plant

By Len Zehr iBio (NYSE American:IBIO) has developed an industry-leading plant-based gene-expression technology to rapidly produce high levels of proteins used for making biologics at its contract development and...

December 18, 2018

Feature

Canopy Health to expand clinical mandate with Constellation Brands investment

Canopy Health Innovations, the research subsidiary of Canopy Growth (TSX:WEED; NYSE:CGC) that focuses on the development of therapeutic and natural health cannabis products, will get a big boost from a blockbuster $5...

December 11, 2018

Feature

Zuga Medical readying U.S. rollout of ZugaLink cloud platform to support digital dentistry

Closely-held Zuga Medical expects to roll out its digital dental implant solution, known as ZugaLink, across the U.S. in 2019. “Digital dentistry is the future of dentistry, with computer-aided design (CAD), computer...

December 4, 2018

Feature

Penta Medical commercializing wearable cold laser therapy device for chronic and acute injuries

Closely-held Penta Medical is now on the sales and marketing trail, targeting sports teams, orthopedic doctors and physical therapists with its PentaVO device. The wearable cold laser therapy and data collection device...

November 27, 2018

Author - Leonard Zehr

MIT-led research team unveil oral insulin capsule for Type 2 diabetes

Interface Biologics to focus future growth in biotech with local drug delivery platform

Karius diagnostic test enabling precision medicine for infectious diseases

Novavax to report key vaccine data in first quarter

Titan Pharma relaunch of Probuphine paying early dividends

BeyondSpring readies NDA filings for Plinabulin in U.S. and China

iBio spearheading plant-based biopharmaceuticals at CDMO plant

Canopy Health to expand clinical mandate with Constellation Brands investment

Zuga Medical readying U.S. rollout of ZugaLink cloud platform to support digital dentistry

Penta Medical commercializing wearable cold laser therapy device for chronic and acute injuries

General

More